Cydan Information

View Top Employees from Cydan

Cydan is an orphan drug accelerator that identifies and de-risks programs with therapeutic and commercial potential. Cydan focuses on selecting promising assets with well-understood biology and proof-of-concept data in in vivo models from academia, industry and other sources. Data generated during a rigorous de-risking process enables formation of stand-alone companies and strategic partnerships.

Website	http://www.cydanco.com
Employees	7 (0 on RocketReach)
Founded	2013
Address	700 Technology Sq Fl 3, Cambridge, Massachusetts 02139, US
Phone	+1 781-687-8000
Technologies	JavaScript , HTML , Google Analytics +11 more (view full list)
Industry	Biotechnology, Business Services General, Orphan Drugs, Pharmaceuticals, Business Services, Science and Engineering, Rare Diseases, Executive Office, Health Care, Genetic Disorders, Medical
Web Rank	16 Million
Keywords	Orphan Drug Development, Therapeutic Solutions, Rare Disease Therapeutics, Drug Development, Drug Discovery, Pharmaceutical Development, Clinical Development, Pharmaceutical Research, Preclinical Development, Drug Commercialization, Biopharmaceutical, Biotechnology, Life Sciences, In Vivo Models, Biotechnology Investment, Pharmaceutical Investment
Competitors	Vertex Pharmaceuticals, Beam Therapeutics, Intellia Therapeutics, Inc., CRISPR Therapeutics, bluebird bio, CureVac, Editas Medicine, Sangamo Therapeutics, Inc., Sarepta Therapeutics, Inc., AavantiBio, Inc. +42 more (view full list)
SIC	SIC Code 283 Companies, SIC Code 28 Companies
NAICS	NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies